Diagnosis of Pulmonary Arterial Hypertension

Clinics in Chest Medicine

Volumn 28, Issue 1, 2007, Pages 59-73

  Trow, Terence K ^a   McArdle, John R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUSCULTATION; BLOOD VESSEL REACTIVITY; CARDIOPULMONARY EXERCISE TEST; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DYSPNEA; ELECTROCARDIOGRAPHY; EXERCISE TEST; FATIGUE; HEART CATHETERIZATION; HEART MURMUR; HEART VENTRICLE SEPTUM DEFECT; HIGH RISK PATIENT; HUMAN; HYPOXEMIA; LABORATORY TEST; LUNG ANGIOGRAPHY; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIMETRY; PATIENT ASSESSMENT; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SEROLOGY; SYMPTOM; THORAX RADIOGRAPHY; THROMBOEMBOLISM; THYROID FUNCTION TEST;

ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTROCARDIOGRAPHY; EXERCISE TEST; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PULMONARY; MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; RESPIRATORY FUNCTION TESTS;

EID: 33847332064     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2006.11.001     Document Type: Review

References (161)

1. Rubin L.J. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126 1 (2004) 7S-10S
2. Rich S., Dantzker D.R., Ayres S.M., et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107 2 (1987) 216-223
3. Wigley F.M., Lima J.A.C., Mayes M., et al. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study). Arthritis Rheum 52 7 (2005) 453-459
4. MacGregor A.J., Canavan R., Knight C., et al. Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology 40 (2001) 453-459
5. Chang B., Schachna L., White B., et al. Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma. J Rheumtol 33 2 (2006) 269-274
6. Pan T.L.T., Thumboo J., and Boey M.L. Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus 9 (2000) 338-342
7. Johnson S.R., Gladman D.D., Urowitz M.B., et al. Pulmonary hypertension in systemic lupus. Lupus 13 (2004) 506-509
8. Hadengue A., Behhayoun M.K., Lebree D., et al. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 100 2 (1991) 520-528
9. Ramsay M.A., Simpson B.R., Nguyen A.T., et al. Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg 3 5 (1997) 494-500
10. Starkel P., Vera A., Gunson B., et al. Outcome of liver transplantation for patients with pulmonary hypertension. Liver Transpl 8 4 (2002) 382-388
11. Krowka M.J. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation. Clin Chest Med 26 4 (2005) 587-597
12. Brenot F., Herve P., Petitpretz P., et al. Primary pulmonary hypertension and fenfluramine use. Br Heart J 70 6 (1993) 537-541
13. Abenhaim L., Moride Y., Brenot F., et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 335 9 (1996) 609-616
14. Collins F.S., and Orringer E.P. Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies. Am J Med 73 (1982) 814-820
15. Gladwin M.T., Sachdev V., Jison M.L., et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 350 9 (2004) 886-895
16. Minter K., and Gladwin M.T. Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research. Am J Respir Crit Care Med 164 (2001) 2016-2019
17. Derchi G., and Forni G.L. Therapeutic approaches to pulmonary hypertension in hemoglobinopathies. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathy. Ann N Y Acad Sci 1054 (2005) 471-475
18. Aessopos A., Farmakis D., Deftereos S., et al. Thalassemia heart disease. A comparative evaluation of thalassemia major and thalassemia intermedia. Chest 127 5 (2005) 1523-1530
19. Haque A.K., Gokhale S., Rampy B.A., et al. Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. Hum Pathol 33 (2002) 1037-1043
20. McGoon M., Gutterman D., Steen V., et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension. ACCP evidence-based clinical practice guidelines. Chest 126 1 (2004) 14S-34S
21. Bull T.M. Physical examination in pulmonary arterial hypertension. Advances in Pulmonary Hypertension 4 3 (2005) 6-10
22. Rios J.C., Massumi R.A., Breesman W.T., et al. Auscultatory features of acute tricuspid regurgitation. Am J Cardiol 23 1 (1969) 4-11
23. Kaplan S., and Adolph R.J. Pulmonic valve stenosis in adults. Cardiovasc Clin 10 (1979) 327-329
24. In: Braunwald E. (Ed). Heart disease: a textbook of cardiovascular medicine (1997), WB Saunders Company, New York
25. Leatham A., and Segal B. Auscultatory and phonocardiographic signs of ventricular septal defect with left-to-right shunt. Circulation 25 (1962) 318-327
26. Newburger J.W., Rosenthal A., Williams R.G., et al. Noninvasive tests in the initial evaluation of heart murmurs in children. N Engl J Med 308 2 (1983) 61-64
27. Trembath R.C., Thomson J.R., Machado R.D., et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 345 5 (2001) 325-334
28. Holcomb B.W., Loyd J.E., Ely E.W., et al. Pulmonary veno-occlusive disease. A case series and new observations. Chest 118 6 (2000) 1671-1679
29. Alegro S., Morrison D., Ovitt T., et al. Noninvasive detection of pulmonary hypertension. Clin Cardiol 7 (1984) 148-156
30. Ahern G.S., Tapson V.F., Rebetz A., et al. Electrocardiography to define clinical status of primary pulmonary hypertension and pulmonary arterial hypertension secondary to collagen vascular disease. Chest 122 2 (2002) 524-527
31. Hlaing T., Donglin G., Zhao X., et al. The QT and Tp-e intervals in left and right chest leads: comparison between patients with systemic and pulmonary hypertension. Journal of Electrocardiography 38 (2005) 154-158
32. Bossone E., Pacioco G., Iarussi D., et al. The role prognostic role of the ECG in primary pulmonary hypertension. Chest 121 2 (2002) 513-518
33. Kanemoto N. Electrocardiogram in primary pulmonary hypertension. Eur J Cardiol 12 (1980) 181-193
34. Kanemoto N. Electrocardiographic and hemodynamic correlations in primary pulmonary hypertension. Angiology 39 9 (1988) 781-787
35. Patrat J.F., Jondeau G., Dubourg O., et al. Left main coronary artery compression during primary pulmonary hypertension. Chest 112 3 (1997) 842-843
36. Lupi E., Dumont C., Tejada V.M., et al. A radiologic index of pulmonary arterial hypertension. Chest 68 (1975) 28-31
37. Matthay R.A., Schwarz M.I., Ellis J.H., et al. Pulmonary artery hypertension in chronic obstructive pulmonary disease: determination by chest radiography. Invest Radiol 16 2 (1981) 95-100
38. Chetty K.G., Brown S.E., and Light R.W. Indentification of pulmonary hypertension in chronic obstructive pulmonary disease from routine chest radiographs. Am Rev Respir Dis 126 2 (1982) 338-341
39. Rich S., Pietra G.G., Kieras K., et al. Primary pulmonary hypertension: radiographic and scintigraphic patterns of histologic subtypes. Ann Intern Med 105 4 (1986) 449-502
40. Woodruff W.W., Hoeck B.E., Chitwood W.R., et al. Radiographic findings in pulmonary hypertension from unresolved embolism. AJR Am J Roentgenol 144 (1985) 681-686
41. Schmidt H.C., Kauczor H.U., Schild H.H., et al. Pulmonary hypertension in patients with chronic pulmonary thromboembolism: chest radiograph and CT evaluation before and after surgery. Eur Radiol 6 (1996) 817-825
42. Stein P.D., Anthanasoulis C., Greenspan R.H., et al. Relation of plain chest radiographic findings to pulmonary arterial pressure and arterial blood oxygen levels in patients with acute pulmonary embolism. Am J Cardiol 69 (1992) 394-396
43. Sun X.G., Hansen J.E., Oudiz R.J., et al. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol 41 (2003) 1028-1035
44. Meyer F.J., Lozznitzer D., Kristen A.V., et al. Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension. Eur Respir J 25 1 (2005) 125-130
45. Viner S.M., Bagg B.R., Auger W.R., et al. The management of pulmonary hypertension secondary to chronic thromboembolic disease. Prog Cardiovasc Dis 37 2 (1994) 79-92
46. Morris T.A., Auger W.R., Ysrael M.Z., et al. Parenchymal scarring is associated with restrictive spirometric defects in patients with chronic thromboembolic pulmonary hypertension. Chest 110 2 (1996) 399-403
47. Romano A.M., Tomaselli S., Gualtieri G., et al. Respiratory function in precapillary pulmonary hypertension. Monaldi Arch Chest Dis 48 3 (1993) 201-204
48. Steenhius L.H., Groen H.J.M., Koeter G.H., et al. Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension. Eur Respir J 16 (2000) 276-281
49. Mohamed R., Freeman J.W., Guest P.J., et al. Pulmonary gas exchange in liver transplant candidates. Liver Transpl 8 9 (2002) 802-808
50. Sulica R., Teirstein A.S., Kakarla S., et al. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Chest 128 3 (2005) 1483-1489
51. Owens G.R., Fino G.J., Herbert D.L., et al. Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma. Chest 84 5 (1984) 546-550
52. Chang B., Wigley F.M., White B., et al. Scleroderma patients with combined pulmonary hypertension and interstitial lung disease. J Rheumatol 30 11 (2003) 2398-2405
53. Steen V.D., Graham G., Conte C., et al. Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 35 7 (1992) 765-770
54. Stupi A.M., Steen V.D., Owens G.R., et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 29 4 (1986) 515-524
55. Scorza R., Caronni M., Bassi S., et al. Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis. Ann N Y Acad Sci 966 (2002) 238-246
56. Denton C.P., Cailes J.B., Phillips G.D., et al. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 36 2 (1997) 239-243
57. Rafanan A.L., Golish J.A., Dinner D.S., et al. Nocturnal hypoxemia is common in primary pulmonary hypertension. Chest 120 3 (2001) 894-899
58. Schulz R., Baseler G., Ghofrani H.A., et al. Nocturnal periodic breathing in primary pulmonary hypertension. Eur Respir J 19 (2002) 658-663
59. Murata I., Kihara H., Shinohara S., et al. Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes. Jpn Circ J 56 (1992) 983-991
60. Borgenson D.D., Seward J.B., Miller Jr. F.A., et al. Frequency of Doppler measurable pulmonary artery pressures. J Am Soc Echocardiogr 9 6 (1996) 832-837
61. Hinderliter A.L., Willis P.W., Barst R.J., et al. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Circulation 95 (1997) 1479-1486
62. Ommen S.R., Nishimura R.A., Hurrell D.G., et al. Assessment of right atrial pressure with 2-dimensional and Doppler echocardiography: a simultaneous catheterization and echocardiographic study. Mayo Clin Proc 75 1 (2000) 24-29
63. Arcasoy S.M., Christie J.D., Ferrari V.A., et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 167 (2003) 735-740
64. Himelman R.B., Struve S.N., Brown J.K., et al. Improved recognition of cor pulmonale in patients with severe chronic obstructive pulmonary disease. Am J Med 84 (1988) 891-898
65. Himelman R.B., Stulbarg M., Kircher B., et al. Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease. Circulation 79 4 (1989) 863-871
66. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43(12 Suppl S):40S-7S.
67. Naeije R., and Torbicki A. More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. Eur Respir J 8 (1995) 1445-1449
68. Penning S., Robinson K.D., Major C.A., et al. A comparison of echocardiography and pulmonary artery catheterization for evaluation of pulmonary artery pressures in pregnant patients with suspected pulmonary hypertension. Am J Obstet Gynecol 184 7 (2001) 1568-1570
69. McQuillan B.M., Picard M.H., Leavitt M., et al. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 104 (2001) 2797-2802
70. Bossone E., Rubenfire M., Bach D.S., et al. Range of tricuspid regurgitation velocity at rest and during exercise in normal adult men: implications for the diagnosis of pulmonary hypertension. J Am Coll Cardiol 33 (1999) 1662-1666
71. Kim W.R., Krowka M.J., Plevak D.J., et al. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl 6 (2000) 453-458
72. Pilatis N.D., Jacobs L.E., Rerkpattanapipat P., et al. Clinical predictors of pulmonary hypertension in patients undergoing liver transplant evaluation. Liver Transpl 6 1 (2000) 85-91
73. Torregrosa M., Genesca J., Gonzalez A., et al. Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates. Transplantation 71 4 (2001) 572-574
74. Shapiro S.M., Oudiz R.J., Cao T., et al. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am Coll Cardiol 30 2 (1997) 343-349
75. Chan K.L., Currie P.J., Seward J.B., et al. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. J Am Coll Cardiol 9 3 (1987) 549-554
76. Currie P.J., Seward J.B., Chan K.L., et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol 6 4 (1985) 750-756
77. Yock P.G., and Popp R.L. Noninvasive estimation of right ventricular ultrasound in patients with tricuspid regurgitation. Circulation 70 4 (1984) 657-662
78. Bossone E., Duong-Wagner T.H., Paciocco G., et al. Echocardiographic features of primary pulmonary hypertension. J Am Soc Echocardiogr 12 (1999) 655-662
79. Gorscan J., Edwards T.D., Ziady G.M., et al. Transesophageal echocardiography to evaluate patients with severe pulmonary hypertension for lung transplantation. Ann Thorac Surg 59 (1995) 717-722
80. Humbert M., Maitre S., Capron F., et al. Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis. Am J Respir Crit Care Med 157 (1998) 1681-1685
81. Resten A., Maitre S., Humbert M., et al. Pulmonary arterial hypertension: thin-section CT predictors of epoprostenol therapy failure. Radiology 222 3 (2002) 782-788
82. Mellins R.B., Levine O.R., and Fishman A.P. Effect of systemic and pulmonary venous hypertension on pleural and pericardial fluid accumulation. J Appl Physiol 29 5 (1970) 564-569
83. Raymond R.J., Hinderliter A.L., Willis P.W., et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 39 7 (2002) 1214-1219
84. Blanchard D.G., and Dittrich H.C. Pericardial adaptation in severe chronic pulmonary hypertension. An intraoperative transesophageal echocardiographic study. Circulation 85 4 (1992) 1414-1422
85. Himelman R.B., Stulbarg M.S., Lee E., et al. Noninvasive evaluation of pulmonary artery systolic pressures during dynamic exercise by saline-enhanced Doppler echocardiography. Am Heart J 119 3 (1990) 685-688
86. Marwick T.H. Progress in stress echocardiography. Application of stress echocardiography to the evaluation of non-coronary heart disease. Eur J Echocardiogr 1 3 (2000) 171-179
87. Kuecherer H.F., Will M., da Silva K.G., et al. Contrast-enhanced Doppler ultrasound for noninvasive assessment of pulmonary artery pressure during exercise in patients with chronic congestive heart failure. Am J Cardiol 78 2 (1996) 229-232
88. Voelker W., Jacksch R., Dittman H., et al. Validation of continuous-wave Doppler measurements of mitral valve gradients during exercise-a simultaneous Doppler-catheter study. Eur Heart J 10 (1989) 737-746
89. Leavitt J.I., Coats M.H., and Falk R.H. Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve: a Doppler echocardiographic study. J Am Coll Cardiol 17 7 (1991) 1520-1526
90. Cheriex E.C., Pieters F.A.A., Janssen J.H.A., et al. Value of exercise Doppler-echocardiography in patients with mitral stenosis. Int J Cardiol 45 (1994) 219-226
91. Schwamenthal E., Vered Z., Agranat O., et al. Impact of atrioventricular compliance on pulmonary artery pressure in mitral stenosis. An exercise echocardiographic study. Circulation 102 (2000) 2378-2384
92. Tunick P.A., Freedberg R.S., Gargiulo A., et al. Exercise echocardiography as an aid to clinical decision making in mitral valve disease. J Am Soc Echocardiogr 5 (1992) 225-230
93. Bossone E., Avelar E., Bach D.S., et al. Diagnostic value of resting tricuspid regurgitation velocity and right ventricular ejection flow parameters for the detection of exercise induced pulmonary arterial hypertension. Int J Card Imaging 16 (2000) 429-436
94. Morelli S., Ferrante L., Sgreccia A., et al. Pulmonary hypertension is associated with impaired exercise performance in patients with systemic sclerosis. Scand J Rheumatol 29 (2000) 236-242
95. Mininni S., Diricatti G., Vono M.C., et al. Noninvasive evaluation of right ventricle systolic pressure during dynamic exercise by saline-enhanced Doppler echocardiography in progressive systemic sclerosis. Angiology 47 5 (1996) 467-474
96. Winslow T.M., Ossipov M., Redberg R.F., et al. Exercise capacity and hemodynamics in systemic lupus erythematosus: a Doppler echocardiographic exercise study. Am Heart J 126 2 (1993) 410-414
97. Raeside D.A., Chalmers G., Clelland J., et al. Pulmonary artery pressure variation in patients with connective tissue disease: 24 hour ambulatory pulmonary artery pressure monitoring. Thorax 53 (1998) 857-862
98. Grunig E., Janssen B., Mereles D., et al. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 102 (2000) 1145-1150
99. Rindermann M., Grunig E., von Hippel A., et al. Primary pulmonary hypertension may be a heterogeneous disease with a second locus on chromosome 2q31. J Am Coll Cardiol 41 12 (2003) 2237-2244
100. Fedullo P.F., Auger W.R., Kerr K.M., et al. Chronic thromboembolic pulmonary hypertension. N Engl J Med 345 20 (2001) 1465-1472
101. Pengo V., Lensing A.W.A., Prins M.H., et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350 22 (2004) 2257-2264
102. Fishman A.J., Moser K.M., and Fedullo P.F. Perfusion lung scans vs. pulmonary angiography in evaluation of suspected primary pulmonary hypertension. Chest 84 6 (1983) 679-683
103. D'Alonzo G.E., Bower J.S., and Dantzker D.R. Differentiation of patients with primary and thromboembolic pulmonary hypertension. Chest 85 4 (1984) 457-461
104. Chapman P.J., Bateman E.D., and Benatar S.R. Primary pulmonary hypertension and thromboembolic pulmonary hypertension-similarities and differences. Respir Med 84 6 (1990) 485-488
105. Worsley D.F., Palevsky H.I., and Alavi A. Ventilation-perfusion lung scanning in the evaluation of pulmonary hypertension. J Nucl Med 35 5 (1994) 793-796
106. Ryan K.L., Fedullo P.F., Davis G.B., et al. Perfusion scan findings understate the severity of angiographic and hemodynamic compromise in chronic thromboembolic pulmonary hypertension. Chest 93 6 (1988) 1180-1185
107. Tardivon A.A., Musset D., Maitre S., et al. Role of CT in chronic pulmonary embolism: comparison with pulmonary angiography. J Comput Assist Tomogr 17 3 (1993) 345-351
108. Remy-Jardin M., Duhamel A., Deken V., et al. Systemic collateral supply in patients with chronic thromboembolic and primary pulmonary hypertension: assessment with multi-detector row helical CT angiography. Radiology 235 (2005) 274-281
109. Heinrich M., Uder M., Tscholl D., et al. CT findings in chronic thromboembolic pulmonary hypertension. Predictors of hemodynamic improvement after pulmonary thromboendarterectomy. Chest 127 5 (2005) 1606-1613
110. Bergin C.J., Hauschildt J., Rios G., et al. Accuracy of MR angiography compared with radionuclide scanning in identifying the cause of pulmonary arterial hypertension. AJR Am J Roentgenol 168 (1997) 1549-1555
111. Ley S., Kauczor H.U., Heussel C.P., et al. Value of contrast-enhanced MR angiography and helical CT angiography in chronic thromboembolic pulmonary hypertension. Eur Radiol 13 (2003) 2365-2371
112. Kreitner K.F.J., Ley S., Kauczor H.U., et al. Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques. Radiology 232 (2004) 535-543
113. Nikolaou K., Schoenberg S.O., Attenberger U., et al. Pulmonary arterial hypertension: diagnosis with fast perfusion MR imaging and high-spatial-resolution MR angiography-preliminary experience. Radiology 236 (2005) 694-703
114. McLauglin V.V., Channick R., Robbins I.M., et al. Integrating current strategies for continuing assessment of pulmonary arterial hypertension. Advances in Pulmonary Hypertension 4 3 (2005) 26-30
115. Rich S., Kieras K., Hart K., et al. Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol 8 6 (1986) 1307-1311
116. Iserin R.A., Yaneva M., Weiner E., et al. Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med 93 (1992) 307-312
117. Steen V.D., Ziegler G.L., Rodnan G.P., et al. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum 27 2 (1984) 125-131
118. Okano Y., Steen V.D., and Medsger T.A. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum 35 1 (1992) 95-100
119. Mitri G.M., Lucas M., Fertig N., et al. A comparison between anti-Th/To and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum 48 1 (2003) 203-209
120. Ulanet D.B., Wigley F.M., Gelber A.C., et al. Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension. Arthritis Rheum 49 1 (2003) 85-92
121. Sacks D.G., Okano Y., Steen V.D., et al. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody. J Rheumatol 23 4 (1996) 639-642
122. Falcao C.A., Alves I.C., Chahade W.H., et al. Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus. Arq Bras Cardiol 79 3 (2002) 285-291
123. Asherson R.A., Higgenbottam T.M., Dinh Xuan A.T., et al. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 17 10 (1990) 1292-1298
124. Petitpretz P., Brenot F., Azarian R., et al. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. Circulation 89 6 (1994) 2722-2727
125. Ma R.C., and Chow C.C. Thyrotoxicosis as a risk factor for pulmonary arterial hypertension. Ann Intern Med 143 4 (2005) 282-292
126. Ma R.C., Cheng A.Y., So W.Y., et al. Thyrotoxicosis and pulmonary hypertension. Am J Med 1128 8 (2005) 927-928
127. Roberts K.E., Barst R.J., McElroy J.J., et al. Bone morphogenetic protein receptor 2 mutations in adults and children with idiopathic pulmonary arterial hypertension: association with thyroid disease. Chest 128 6 Suppl (2005) 618S
128. Merce J., Ferras S., Oltra C., et al. Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler echocardiographic study. Am J Med 118 2 (2005) 126-131
129. Chu J.W., Kao P.N., Faul J.L., et al. High prevalence of autoimmune thyroid disease in pulmonary hypertension. Chest 122 5 (2002) 1668-1673
130. Curnock A.L., Dweik R.A., Higgins B.H., et al. High prevalence of hypothyroidism in patients with primary pulmonary hypertension. Am J Med Sci 318 5 (1999) 289-292
131. Nakchbandi I.A., Wirth J.A., and Inzucchi S.E. Pulmonary hypertension caused by Graves' thyrotoxicosis: normal pulmonary hemodynamics restored by (131) I treatment. Chest 116 5 (1999) 1483-1485
132. Lozano H.F., and Sharma C.N. Reversible pulmonary hypertension, tricuspid regurgitation and right-sided heart failure associated with hyperthyroidism: case report and review of the literature. Cardiol Rev 12 6 (2004) 299-305
133. Laffon E., Vallet C., Bernard V., et al. A computed method for noninvasive MRI assessment of pulmonary arterial hypertension. J Appl Physiol 96 (2004) 463-468
134. Saba T.S., Foster J., Cockburn M., et al. Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure. Eur Respir J 20 (2002) 1519-1524
135. Boxt L.M., Katz J., Kolb T., et al. Direct quantification of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension. J Am Coll Cardiol 19 7 (1992) 1508-1515
136. Frank H., Globits S., Glogar D., et al. Detection and quantification of pulmonary hypertension with MR imaging: results in 23 patients. AJR Am J Roentgenol 161 (1993) 27-31
137. Katz J., Whang J., Boxt L.M., et al. Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging. J Am Coll Cardiol 21 6 (1993) 1475-1481
138. Roeleveld R.J., Marcus J.T., Boonstra A., et al. A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging 22 (2005) 67-72
139. Waxman A.B. Pulmonary function test abnormalities in pulmonary vascular disease and chronic heart failure. Clin Chest Med 22 4 (2001) 751-758
140. Janicki J.S., Weber K.T., Likoff M.J., et al. Exercise testing to evaluate patients with primary vascular disease. Am Rev Respir Dis 129 2 (1984) S93-S95
141. Sun X.G., Hansen J.E., Oudiz R.J., et al. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 104 (2001) 429-435
142. Yasunobu Y., Oudiz R.J., Sun X.G., et al. End-tidal PCO2 abnormality in patients with primary pulmonary hypertension. Chest 127 5 (2005) 1637-1646
143. Hansen J.E., Sun X.G., Yasunobu Y., et al. Reproducibility of cardiopulmonary exercise measurements in patients with pulmonary arterial hypertension. Chest 126 3 (2004) 816-824
144. Barst R.J., Langleben D., Frost A., et al. Sitaxentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 169 (2004) 441-447
145. Iwase T., Nagaya N., Ando M., et al. Acute and chronic effects of surgical thromboendarterectomy on exercise capacity and ventilatory efficiency in patients with chronic thromboembolic pulmonary hypertension. Heart 86 (2001) 188-192
146. Cahalin L.P., Mathier M.A., Semigran M.J., et al. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 110 2 (1996) 325-332
147. Miyamoto S., Nagaya N., Satoh T., et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 161 (2000) 487-492
148. Wax D., Garofano R., and Barst R.J. Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension. Chest 116 4 (1999) 914-920
149. Sitbon O., Humbert M., Nunes H., et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension. Prognostic factors and survival. J Am Coll Cardiol 40 4 (2002) 780-788
150. Wensel R., Opitz C.F., Anker S.D., et al. Assessment in patients with primary pulmonary hypertension. Importance of cardiopulmonary exercise testing. Circulation 106 (2002) 319-324
151. Hoeper M.M., Markevych I., Spiekerkoetter E., et al. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J 26 5 (2005) 858-863
152. Oudiz R.J., and Langleben D. Cardiac catheterization in pulmonary arterial hypertension: an updated guide to proper use. Advances in Pulmonary Hypertension 4 3 (2005) 15-25
153. Nootens M., Wolfkiel C.J., Chomka E.V., et al. Understanding right and left ventricular systolic function and interactions at rest and exercise in primary pulmonary hypertension. Am J Cardiol 75 (1995) 374-377
154. Shapiro B.P., Nishimura R.A., McGoon M., et al. Diagnostic dilemmas: diastolic heart failure causing pulmonary hypertension and pulmonary hypertension causing diastolic dysfunction. Advances in Pulmonary Hypertension 5 1 (2006) 13-20
155. D'Alonzo G.E., Barst R.J., Ayres S.M., et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115 5 (1991) 343-349
156. Rich S., and Brundage B.H. High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation 76 1 (1987) 135-141
157. Sitbon O., Humber M., Jais X., et al. Long-term response to calcium channel blockers in idiopathic pulmonary hypertension. Circulation 111 (2005) 3105-3111
158. McLaughlin V.V., Shillington A., and Rich S. Survival in primary pulmonary hypertension. The impact of epoprostenol therapy. Circulation 106 (2002) 1477-1482
159. Kawut S.M., Horn E.M., Berekashvili K.K., et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 95 (2005) 199-203
160. Rich S., Kaufmann E., and Levy P.S. The effect of high dose calcium-channel blockers on survival in pulmonary hypertension. N Engl J Med 327 2 (1992) 76-81
161. Rich S., D'Alonzo G.E., Dantzker D., et al. Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension. Am J Cardiol 55 1 (1985) 159-163